| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on January 2, 2003
From the Department of Pharmacology, Monash University, Melbourne, Victoria, Australia. * To whom correspondence should be addressed. E-mail: barbara.kemp{at}med.monash.edu.au.
Abstract--Nitric oxide (NO) plays an important role in the control of vascular tone. Traditionally, its vasorelaxant activity has been attributed to the free radical form of NO (NO•), yet the reduced form of NO (NO-) is also produced endogenously and is a potent vasodilator of large conduit arteries. The effects of NO- in the resistance vasculature remain unknown. This study examines the activity of NO- in rat small isolated mesenteric resistance-like arteries and characterizes its mechanism(s) of action. With the use of standard myographic techniques, the vasorelaxant properties of NO• (NO gas solution), NO- (Angeli's salt), and the NO donor sodium nitroprusside were compared. Relaxation responses to Angeli's salt (pEC50=7.51±0.13, Rmax=95.5±1.5%) were unchanged in the presence of carboxy-PTIO (NO• scavenger) but those to NO• and sodium nitroprusside were inhibited. L-Cysteine (NO- scavenger) decreased the sensitivity to Angeli's salt (P<0.01) and sodium nitroprusside (P<0.01) but not to NO•. The soluble guanylate cyclase inhibitor ODQ (3 and 10 µmol/L) concentration-dependently inhibited relaxation responses to Angeli's salt (41.0±6.0% versus control 93.4±1.9% at 10 µmol/L). The voltage-dependent K+ channel inhibitor 4-aminopyridine (1 mmol/L) caused a 9-fold (P<0.01) decrease in sensitivity to Angeli's salt, whereas glibenclamide, iberiotoxin, charybdotoxin, and apamin were without effect. In combination, ODQ and 4-aminopyridine abolished the response to Angeli's salt. In conclusion, NO- functions as a potent vasodilator of resistance arteries, mediating its response independently of NO• and through the activation of soluble guanylate cyclase and voltage-dependent K+ channels. NO- donors may represent a novel class of nitrovasodilator relevant for the treatment of cardiovascular disorders such as angina.
Revised on January 23, 2003
NO- Activates Soluble Guanylate Cyclase and Kv Channels to Vasodilate Resistance Arteries
Jennifer C. Irvine;
This article has been cited by other articles:
![]() |
A. Zeller, M. V. Wenzl, M. Beretta, H. Stessel, M. Russwurm, D. Koesling, K. Schmidt, and B. Mayer Mechanisms Underlying Activation of Soluble Guanylate Cyclase by the Nitroxyl Donor Angeli's Salt Mol. Pharmacol., November 1, 2009; 76(5): 1115 - 1122. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Miller, M. M. Cherney, A. J. Lee, N. E. Francoleon, P. J. Farmer, S. B. King, A. J. Hobbs, K. M. Miranda, J. N. Burstyn, and J. M. Fukuto The Effects of Nitroxyl (HNO) on Soluble Guanylate Cyclase Activity: INTERACTIONS AT FERROUS HEME AND CYSTEINE THIOLS J. Biol. Chem., August 14, 2009; 284(33): 21788 - 21796. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Favaloro and B. K. Kemp-Harper Redox variants of NO (NO{middle dot} and HNO) elicit vasorelaxation of resistance arteries via distinct mechanisms Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1274 - H1280. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Paolocci and D. A. Wink The shy Angeli and his elusive creature: the HNO route to vasodilation Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1217 - H1220. [Full Text] [PDF] |
||||
![]() |
S. Lancel, J. Zhang, A. Evangelista, M. P. Trucillo, X. Tong, D. A. Siwik, R. A. Cohen, and W. S. Colucci Nitroxyl Activates SERCA in Cardiac Myocytes via Glutathiolation of Cysteine 674 Circ. Res., March 27, 2009; 104(6): 720 - 723. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Irvine, J. L. Favaloro, R. E. Widdop, and B. K. Kemp-Harper Nitroxyl Anion Donor, Angeli's Salt, Does Not Develop Tolerance in Rat Isolated Aortae Hypertension, April 1, 2007; 49(4): 885 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Favaloro and B. K. Kemp-Harper The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature Cardiovasc Res, February 1, 2007; 73(3): 587 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Rogers, G. M. Dick, J. D. Knudson, M. Focardi, I. N. Bratz, A. N. Swafford Jr., S.-i. Saitoh, J. D. Tune, and W. M. Chilian H2O2-induced redox-sensitive coronary vasodilation is mediated by 4-aminopyridine-sensitive K+ channels Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2473 - H2482. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wareing, X. Bai, F. Seghier, C. M. Turner, S. L. Greenwood, P. N. Baker, M. J. Taggart, and G. K. Fyfe Expression and function of potassium channels in the human placental vasculature Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R437 - R446. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Fountain, A. Cheong, R. Flemming, L. Mair, A. Sivaprasadarao, and D. J. Beech Functional up-regulation of KCNA gene family expression in murine mesenteric resistance artery smooth muscle J. Physiol., April 1, 2004; 556(1): 29 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Wink, K. M. Miranda, T. Katori, D. Mancardi, D. D. Thomas, L. Ridnour, M. G. Espey, M. Feelisch, C. A. Colton, J. M. Fukuto, et al. Orthogonal properties of the redox siblings nitroxyl and nitric oxide in the cardiovascular system: a novel redox paradigm Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2264 - H2276. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |